Background: One of the barriers identified in palliative care research is the lack of common criteria to describe the population. Aim: The aim of this Delphi process was to obtain consensus on a basic set of core variables to describe or classify a palliative care cancer population. Design and setting: This was a five-step international Delphi exercise. A total of 117 experts were invited to participate. Based on a literature review and analyses of existing minimum datasets for national databases, a list of 18 proposed variables was presented in the first Delphi round. The two first rounds focused on which variables to include, and several new variables were proposed. The three last Delphi rounds focused on how the agreed variables should be recorded. Consensus was defined as at least 70% agreement. Results: A total of 64 experts from 30 countries participated. High consensus was reached on 31 variables, divided between a 'patient form' -date of birth, gender, living situation, education, ethnicity and 12 symptoms -and a 'health-care personnel form' -patient's date of birth, principal diagnosis, date of the principal diagnosis, stage of the cancer disease, site of metastases, present anticancer treatment, main additional diagnoses, stage of the additional diagnoses, medication, weight loss, performance status, cognitive impairment, place of care and provision of care. It was more difficult to agree upon how to record the variables, but consensus was reached on all except ethnicity, vomiting and weight loss. Conclusion: Consensus was reached on a set of core variables and how they should be recorded.
Introduction
Whom is the study about? This is one of the key questions readers ask themselves when reading an article. A clear description of the patient population is the only way to answer this question and allow the readers to judge whether the results are applicable to their own clinical setting. Describing the population in sufficient detail is a prerequisite for generalizing study findings or comparing results across trials.
External validity, that is, generalizability of study results, is a major challenge in palliative care research. Palliative care populations may differ extensively with respect to age, diagnoses, symptom burden, functional status and survival. 1, 2 As a consequence, all relevant information should be included when reporting on a palliative care study sample. The need to standardize this reporting has been recognized by several authors. [3] [4] [5] [6] [7] The project 'PRISMA', funded by The European Commission's Seventh Framework Programme, delivered an integrated programme to coordinate research priorities and practice in end-of-life care, defined as care in the last year of life. 8 As part of PRISMA, the first comprehensive survey of end-of-life cancer care research in Europe was conducted, mapping research activities and priorities. 9 The survey results were further explored in a workshop aiming to identify barriers to end-of-life care research and look for solutions to overcome the barriers and strengthen the research. The workshop identified the lack of consensus on common definitions, outcomes, and methodology as a major research barrier. 10 Based on this result, the European Palliative Care Research Centre (PRC) 11 in collaboration with the European Association for Palliative Care Research Network (EAPC-RN) 12 started a process to develop and reach consensus on a basic set of variables to describe a palliative care population.
The work towards a common set of descriptors has been done in two steps. First, a systematic literature review was conducted to explore which variables have been used to characterize adult palliative care cancer populations in randomized controlled trials (RCTs). 13 Data from 336 included full-text articles confirmed the lack of standards on how to describe the population and showed that very few variables were consistently recorded and reported.
This article reports on the second step, a consensus process with the aim to agree on a basic set of core variables necessary and sufficient to describe a palliative care population. The underlying hypothesis was that it would be possible to define a basic set of descriptors to be universally applied in palliative care research as well as in clinical settings, but that a supplementary, modular approach might be necessary for specific studies and/or diseases other than cancer.
Methods
This was a five-step international web-based Delphi process conducted between 2 February and 11 August 2011. The study was coordinated from the PRC at the Norwegian University of Science and Technology (NTNU) in collaboration with the EAPC-RN and the project PRISMA.
Size and composition of the panel
In total, 103 palliative care researchers and clinicians from 35 countries and editors of 14 palliative care journals were invited to participate. As part of the project PRISMA, 9, 10 we tried to identify all chairs in palliative care and palliative medicine in Europe. In countries without such chairs, palliative care researchers or other identified contacts were approached. These individuals were identified from the EAPC, Open Society Institute, UK Hospice Information Service, national associations for palliative care and/or palliative medicine in European countries and a number of international contacts and through literature searches. An additional literature search identified authors who had published on how to describe or classify a palliative care population. Board members of the EAPC and EAPC-RN were also invited to participate.
We received 69 responses from the 117 invited contacts, stating their willingness to participate in the Delphi process. In the first round, information about the participants was collected: country of residence, age, gender, physical location of workplace, number of years working within palliative care, professional definition (clinician, researcher or both), professional background and name. Non-responders from earlier rounds were excluded from subsequent rounds.
Methodology of the Delphi process
The Delphi approach engages experts in responding to questions and to give subsequent contributions based on the initial responses. The participants were contacted via e-mail with a link to an online questionnaire using the SelectSurvey.NETv4.066.001 software. 14 Panellists were asked to fill in the questionnaire on behalf of themselves only. They had 2 weeks to complete each round. A reminder was sent to non-responders after 10 days. The deadline was postponed 1 week in all the rounds. The Delphi coordinators gathered, collated and analysed the data (descriptive statistics) and made additional requests for response based on the findings. The responses were strictly confidential, and data were reported only in aggregate form. Most of the questions were mandatory.
First round. The purpose of the first round was to collect ideas. The research group provided a list of 18 variables, divided between a patient form and a health-care personnel form. The selection was based on a systematic literature review, 13 analysis of existing minimum datasets for national palliative care databases [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] and the Resident Assessment Instrument for Palliative Care (RAI-PC). 25 The participants were asked about their level of agreement as to whether the proposed variables should be included in the basic dataset (Table 1 ). They were also given the opportunity to propose new variables. If ≥10% of the respondents proposed the same new variable, it was included in the next Delphi round. The questionnaire for the first Delphi round was pilot tested by 11 experts from our research network.
Second round. The purpose of the second round was to inform the participants about the results of the first round and to rate each variable. The participants were presented with the results from the first round, including the new, added variables and all submitted comments. Based on this information, the participants were asked to rate their level of agreement with each of the 32 proposed variables on the new list.
Third round. The purpose of the third round was to inform about the final list of variables and to collect ideas on how these variables should be assessed and recorded. For each variable, the research group made one or more proposals for how to assess it, based on the same material as above. 13, [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] The participants were free to select one of the proposed assessment methods, if considered optimal, or suggest and specify another way to measure the variable. The questionnaire made for this round was pilot tested by five experts from our research network.
Fourth round. The purpose of the fourth round was to inform about the results from the third round and to make a selection on how the variables should be assessed and recorded. The participants were asked to select one alternative for each variable.
Fifth round. The purpose of the fifth round was to inform about the results from the fourth round and to reach consensus on how the remaining variables should be recorded. The participants were asked to choose between the two options with the highest level of agreement from the fourth round.
Statistical analysis
Consensus was defined as 70% agreement within the group. Data storage and descriptive statistics were performed using the software SPSS version 19.0.
Ethics
The Regional Committee for Medical and Health Research Ethics, Central Norway, was contacted. Due to the nature of the study, no application was required.
Results

The Delphi panel
The Delphi panel in round 1 consisted of 64 palliative care experts from 30 countries. The background of the expert group is presented in Table 2 . The Delphi process First round. In total, 69 experts were contacted and 64 of them responded. Figure 1 shows a flowchart of the Delphi process. The experts were provided with a list of 18 variables. One of the variables was 'brief symptom assessment'. If the participants agreed that a brief symptom assessment should be part of the dataset, they were presented with a list of the nine symptoms of the revised Edmonton Symptom Assessment System (ESAS-r). [26] [27] [28] Table 3 shows the results from the first and second Delphi rounds. Consensus was reached on 16 items. Three new variables -education, ethnicity and weight loss -and four additional symptoms -insomnia, constipation, vomiting and diarrhoea -were proposed by ≥10% of the respondents.
Second round. In total, 64 experts were contacted and 63 of them responded. The experts were provided with the new list of 32 items (Table 3) . A high level of agreement was reached on all items (range: 81%-100%) except diarrhoea.
Third round. In total, 63 experts were contacted and all responded. They were provided with the list of the 31 agreed variables from round 2 ( Table 4 ) together with proposals for how to measure or record each variable (example given in Table 1 ). Agreement on how to record the following five of the variables was reached: gender, site of metastases, present anticancer treatment, patient's medication and provision of care. Table 4 shows the levels of agreement and how to record the variables.
Fourth round. In total, 63 experts were contacted and 59 responded. The participants were provided with a list of the 26 remaining agreed variables and proposals for how to measure each of them (example shown in Table 1 ). In this round, consensus was reached on how to record 14 variables ( Table 4 ).
Fifth round. In total, 59 experts were contacted and 56 responded. The experts were provided with a list of the 12 remaining variables and asked to choose between the two proposals with the highest level of agreement from the fourth round. Consensus was reached on how to measure nine variables. Table 4 shows the levels of agreement on how to record the items. Consensus was not reached on how to record the following three variables: ethnicity, vomiting and weight loss. Table 5 shows the two proposals given for these three items and the levels of agreement. For the purpose of pilot testing, the research group decided on how these items should be recorded based on the results and comments from previous Delphi rounds.
Discussion
We report here on a Delphi process that resulted in consensus on a set of 31 core variables to describe a palliative care cancer population. As far as we are aware, this is the first internationally anchored minimum dataset for reporting patient characteristics and medical variables in palliative care. The Delphi participants were palliative care experts from Australia, Canada, the United States and 27 countries in Europe. While it was remarkably easy to reach consensus on which variables to include in the dataset, it was more difficult to agree upon how each of them should be measured. Deciding on what constitutes expertise is critical for the validity of the process. In this study, much work was put into getting an extensive international panel. 9, 10 Despite this broad approach, we might have missed a number of experts. On the other hand, the panel members had been working on average 15.1 years in palliative care, indicating a skilled, experienced group.
The focus of the present consensus process was patient characteristics and medical variables. In line with this, the Delphi panel was multiprofessional but with a predominance of physicians (59%). The limited information on central palliative care domains such as psychosocial and spiritual issues represents a limitation of the dataset. However, there is much less international consensus on how to assess, for example, spiritual distress than physical symptoms, and although all aspects of suffering are intertwined, assessment of spiritual and emotional issues probably needs more cultural considerations and adaptations, also within Europe. A new variable was added if proposed by ≥10% of the respondents, and variables within these domains were proposed by too few participants. Future research is needed to identify core dataset items for the other domains of palliative care.
The first invitation to participate was sent to 117 individuals, of whom 69 responded. Non-responders were not chased up, and we cannot exclude a certain selection bias. For instance, all the 8 invited experts from Norway participated, while only 1 of 5 invitees from Italy and 6 of 16 from the United Kingdom.
According to acknowledged Delphi guidelines, a response rate of 70% for each round is required. 29 In our study, the response rate varied from 100% to 92%. The overall response rate was 81%. Reasons for dropping out were not reported. The highest number of dropouts was seen in the last two rounds conducted in the summer. We still believe that this first version of the dataset is well founded, as 63 experts participated in the third round and were informed about the final list of variables with one or more proposals for how to assess each of them.
The language, format and contents of the Delphi round questionnaires, especially the proffered lists of response options, represent additional limitations. We tried to minimize this possible bias by making the process utterly transparent, including all comments and remarks from the respondents in the next round. All the participants were encouraged to read every comment before making a new selection.
For defining consensus, 70% was chosen as the cut-off. In different studies, this ranges from 51% to 100%. 29, 30 In the present study, the level of agreement ranged from 70% to 100%. The level of agreement was lower in the later rounds, focusing on how to record the variables. This probably reflects the plethora of tools and instruments in use, and the lack of international standards and consensus. 31 The Delphi process started with a list of 18 variables. One of the variables was 'brief symptom assessment'. If the participants agreed that a brief symptom assessment should be part of the EAPC basic dataset, they were presented with an additional list of the nine symptoms of the ESAS-r. [26] [27] [28] The ESAS is widely used in clinical practice; 32 it measures the most commonly experienced symptoms in cancer patients and is brief and easy to use. 33 By presenting the ESAS-r in the first round, 97% of the participants were presented with altogether 27 variables, of which only one was discarded (height) and one changed from 'current weight' to 'weight loss' in the course of the consensus process. It is tempting to interpret this as if we managed to include central variables from the start.
After five rounds, consensus was reached on how to record all variables except three. The research group judged that it was unlikely to achieve consensus in further rounds, and the group decided on how to measure the variables for the purpose of pilot testing the dataset. Ethnicity is a challenging variable and triggered a lot of comments from participants. For the purpose of pilot testing the dataset, an open-ended question will be used: 'what is your ethnicity?'. Vomiting was the second variable without consensus about how to assess it. However, 64% chose to record it in the same manner as the other symptoms, using a Numerical Rating Scale (NRS) 0-10. This proposal was supported by the research group to secure a uniform approach. 34 Weight loss was the last variable on which no consensus for assessment was reached. However, the two options on how to record weight loss that received the highest scores were very similar, and the research group decided to follow the recommendation of the European Palliative Care Research Collaborative (EPCRC) Cachexia Guidelines. 35 Some of the participants expressed their concern about whether it would be too difficult for the most fragile patients to use an NRS and proposed to use a Verbal Categorical Scale (VCS)/Likert scale. This option was added in the next Delphi round; nevertheless, the NRS was the chosen scale. Pilot testing of the dataset will be important to judge its feasibility in the frailest patients, and one may test both scale options. It may prove necessary to offer more than one scale option to comply with specific requirements of subgroups of patients or with established practice. Analysis of existing minimum datasets for national palliative care databases was included in the preparatory work for the present Delphi process. [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] There are major differences between these datasets; some of them are survey constructed, while others collect information on individual patients. Analysis showed that only age, gender and diagnosis were common denominators. These three variables are also included in the only previously published initiative to define a framework of variables to classify a palliative care population. 4 The published checklist 36 contains a limited number of demographic and disease-related variables, making it insufficient for describing the sample in clinical trials. Using the EAPC basic dataset as part of such a checklist for authors would assist in evaluating the external validity of a research report and complement methodology-based checklists of internal validity such as CONSORT for RCTs. 37 The aim of this process was to obtain a set of common descriptors necessary and sufficient to describe a palliative care cancer population in clinical studies. However, the ideal situation would be to use the same dataset for research, clinical and policy purposes. We realize that supplementary modules may have to be added for specific studies, diseases or objectives. The balance between a dataset that is clear, simple and user-friendly and at the same time providing sufficient information on patient characteristics is delicate. Pilot testing is necessary to evaluate whether the 'right' variables were included and will probably lead to some adjustment of the contents. Many participants stated their willingness to pilot test the dataset, and they will soon be contacted for further action. In the meantime, we strongly encourage researchers and clinicians to start using the dataset, even though it is likely to evolve over time. PDF files of the dataset will be made available on the PRC and EAPC homepages. Development of an electronic version is in progress.
We also regard it a good basis for national databases, supplemented by relevant quality indicators. Finally, the dataset may serve as a very useful checklist for palliative care journals. Used in this way, the EAPC basic dataset will provide a common language and framework for reporting for researchers, clinicians and other palliative care stakeholders. We therefore appeal to editors of palliative care journals, leaders of research groups and national coordinators to take the lead in the use of the EAPC basic dataset in all palliative care settings.
Conclusion
Palliative care experts from 30 countries were able to reach consensus on a set of 31 core variables to describe a palliative care cancer population. The EAPC basic dataset of patient characteristics and medical variables gives a unique platform for standardizing research and service reporting and could be an important milestone in the development of evidence-based palliative care.
